Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial
Author(s):
Donk, N.W.C.J. van de; Holt, B. van der; Minnema, M.C.; Vellenga, E.; Croockewit, S.; Kersten, M.J.; Borne, P.A. von dem; Ypma, P.; Schaafsma, R.; Weerdt, O. de; Klein, S.K.; Delforge, M.; Levin, M.D.; Bos, G.M.; Jie, K.S.G.; Sinnige, H.; Coenen, J.L.L.M.; Waal, E.G. de; Zweegman, S.; Sonneveld, P.; Lokhorst, H.M.
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-10-31
Language
English
Is part of
Lancet Haematology (2018), Vol. 5, no. 10, p. E479-E492
